Campbell & CO Investment Adviser LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Campbell & CO Investment Adviser LLC
- $1.24 Billion
- Q4 2024
A detailed history of Campbell & CO Investment Adviser LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 19,166 shares of ARWR stock, worth $368,562. This represents 0.03% of its overall portfolio holdings.
Number of Shares
19,166
Previous 143,757
86.67%
Holding current value
$368,562
Previous $2.78 Million
87.06%
% of portfolio
0.03%
Previous 0.21%
Shares
9 transactions
Others Institutions Holding ARWR
# of Institutions
305Shares Held
95.9MCall Options Held
523KPut Options Held
493K-
Black Rock Inc. New York, NY15.7MShares$302 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$234 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$214 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$116 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$101 Million1.89% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.04B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...